An epidemiologic study of hepatocellular carcinoma in Canada

Canadian Journal of Public Health

Volumn 93, Issue 6, 2002, Pages 443-446

  ElSaadany, Susie ^a   Tepper, Martin ^b   Mao, Yang ^a   Semenciw, Robert ^a   Giulivi, Antonio ^a  

^a HEALTH CANADA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CANADIAN CANCER REGISTRATION DATABASE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DEVICE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS C; HUMAN; INFANT; LIVER CELL CARCINOMA; MALE; MATHEMATICAL MODEL; PREDICTION; SEX RATIO;

EID: 0036855428     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405035     Document Type: Article

References (29)

1. Aoki K, Hayakawa N, Kurihara M, Suziki S. Death rates for malignant neoplasms for selected sites by sex and five-year age groups in 33 countries, 1953-57 to 1983-87. Nagoya: University of Nagoya Coop Press, 1992.
2. McLaughlin JR, Sloan MR, Janovjak DP. Cancer Survival in Ontario. Toronto: The Ontario Cancer Treatment and Research Foundation, 1995.
3. Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 1991;12:425-57.
4. Holford TR. Analysing the effects of age, period, and cohort on incidence and mortality rates. Stat Meth Med Res 1992;1:317-37.
5. MacNeill IB. Projection Methods Age-Period Cohort Cancer Data. Internal Technical Report. Ottawa: Cancer Bureau, Health Canada, 1995.
6. MacNeill IB, Mao Y, Xie L, Tang SM. Segmented models for age-period cohort cancer data. Int J Mathematical and Statistical Sci 1995;4:1-10.
7. Joinpoint Regression Program [computer program]. Version 2.3. Washington: National Cancer Institute, 2000.
8. Mathsoft. S-plus 2000 Guide to Statistics, Volume 1. Seattle, WA: Data Analysis Products Division, Mathsoft, 1999.
9. Donato F, Boffetta P, Puoti MA. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998;75:347-54.
10. Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaria T, Payawal DA, et al. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer 1997;80:2060-67.
11. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-801.
12. Chang CC, Yu MW, Lu CF, Yang CS, Chen CJ. A nested case-control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Taiwan. J Med Virol 1994;43:276-80.
13. Mori M, Hara M, Wada I, Hara T, Yamamoto K, Honda M, et al. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 2000;151:131-39.
14. Corrao G, Ferrari P, Zambon A, Torchio P, Arico S, Decarli A. Trends of liver cirrhosis mortality in Europe, 1970-1989: Age-period-cohort analysis and changing alcohol consumption. Int J Epidemiol 1997;26:100-9.
15. Statistics Canada. Health Status of Canadians: Report of the 1991 General Social Survey. Ottawa: Minister of Industry, Science and Technology, 1994;127-35. Catalogue No. 11-612E, No. 8.
16. Statistics Canada. National Population Health Survey 1994-95 Public Use Microdata Files (CD-ROM). Ottawa: Minister of Industry, Science and Technology, 1995. Catalogue No. 82F0001XCB.
17. Statistics Canada. National Population Health Survey 1996-97 Public Use Microdata Files (CD-ROM). Ottawa: Minister of Industry, Science and Technology, 1998. Catalogue No. 82M0009XCB.
18. Smart RG, Suurvali HM, Mann RE. Do drinking surveys predict changes in population-based alcohol problem indicators? Alcohol 2000;35(3):255-58.
19. Tepper M, ElSaadany S. Hepatocellular Carcinoma in Canada: Whither Goest. CASL Single Topic Conference on Hepatocellular Carcinoma - Science and Practice, June 26-27, 1998, Niagara-on the Lake, Canada.
20. Smart RG, Mann RE. Treatment, Alcoholics Anonymous and alcohol controls during the decrease in alcohol problems in Alberta: 1975-1993. Alcohol 1998;33(3):265-72.
21. Health Canada, Blood Borne Pathogens Division. Viral hepatitis and emerging blood-borne pathogens in Canada. Can Commun Dis Rep 2001;27(S3).
22. Health Canada, Blood Borne Pathogens Division. Study on the Immigration from HBV and HCV Areas in Canada. Unpublished Report. Ottawa, Blood Borne Pathogens Division, 1998.
23. Zou S, Tepper M, Giulivi A. Current status of hepatitis C in Canada. Can J Public Health 2000;91(Suppl. 1):S10-S15.
24. Zou S, Tepper M, ElSaadany S. Prediction of hepatitis C burden in Canada. Can J Gastroenterologv 2000; 14(7):575-80.
25. Health Canada, Blood Borne Pathogens Division. Current Status of Hepatitis B in Canada. Internal Report. Ottawa: Blood Borne Pathogens Division, 2000.
26. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998;27(1):273-78.
27. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340(10):745-50.
28. Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer. Lancet 1998;351:214-15.
29. Dinse GE, Umbach DM, Sasco AJ, Hoel DG, Davis DL. Unexplained increases in the cancer incidence in the United States from 1975-1994: Possible sentinel health indicators. Annu Rev Public Health 1999;20:173-209.